Clinical Value Analysis of IgG Antibody Detection in Diagnosis of Chronic Pulmonary Aspergillosis

杨罗曼,周庆涛,贺蓓

DOI: https://doi.org/10.3760/cma.j.cn131368-20191013-01402

2020-01-01

Abstract:Objective:To evaluate the clinical value of aspergillus-specific immunoglobulin G (IgG) antibody in diagnosis of chronic pulmonary aspergillosis.Methods:47 patients who were admitted to Peking University Third Hospital from April 2018 to April 2019 and suspected to have chronic pulmonary aspergillosis infection were studied.The serum 1, 3-β-glucan test (G test), galactomannan (GM) test and aspergillus-specific IgG test were performed on these patients to evaluate the results of the three test methods.Results:According to the clinical classification criteria, there were 26 patients in aspergillosis group, 21 patients in the non-aspergillosis group.The result of serum G test was 36 (10, 160) ng/L, GM test was 0.23(0.15, 0.30) and aspergillus-specific IgG detection was 151.43 (84.61, 322.63) AU/ml in aspergillosis group.In non-aspergillosis group, the result of serum G test was 10 (10, 45) ng/L, GM test was 0.26(0.15, 0.54) and aspergillus-specific IgG detection was 57.90 (42.79, 137.42) AU/ml.The sensitivity of aspergillus-specific IgG detection was 65.4%.The area under receiver operator characteristic curve of aspergillus-specific IgG detection method was 0.785 3.Conclusions:In the clinical diagnosis and treatment of patients with chronic pulmonary aspergillosis, aspergillus-specific IgG antibody detection has a higher detection rate for aspergillus, which can make up for the defects of GM detection, and is beneficial for early diagnosis and timely effective treatment.